CV Sciences, Inc. Announces Launch of PlusCBD™ Pet Product Line Other OTC:CVSI



SAN DIEGO, Nov. 04, 2020 (World NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) solutions, these days introduced the launch of PlusCBD™ Pet, a entire line of hemp extracts formulated exclusively for pet dogs and cats.

Created with the exact trustworthy hemp extracts utilized in CV Sciences’ most effective-marketing CBD merchandise, PlusCBD™ Pet is out there in 250mg and 500mg formats with pet helpful flavors, together with beef, rooster, peanut butter and salmon, as effectively as unflavored. PlusCBD™ Pet will be marketed across the Company’s pure and on-line retail channels, with programs to broaden into the pet specialty channel and food stuff, drug and mass retail channel.

The U.S. Pet CBD marketplace grew to in excess of 10 situations its 2018 dimension in 2019, producing $321 million in revenue, and is projected to attain $563 million by the conclude of 2020, according to Brightfield Team. Growth is getting driven by pet owners wanting for pure alternatives for pets’ health care conditions, together with nervousness, pain, or other severe problems that have not responded very well to other treatments, and is anticipated to make up a $1.7 billion market place by the finish of 2025, based on Brightfield Group knowledge.

“PlusCBD™ Pet presents us with an interesting opportunity to leverage our brand fairness and retail distribution channels to participate in the developing pet CBD marketplace,” reported Joseph Dowling, Main Government Officer, CV Sciences. “We believe that the pet CBD classification will continue to increase as additional investigation demonstrates the overall health rewards of CBD for pet dogs and cats. Our employees have supplemented their pets with our human PlusCBD™ goods for years, now we are delighted to have an option to aid all pet dad and mom love their pets with our relaxing PlusCBD™ Pet products and solutions formulated specifically for animals.”

About CV Sciences, Inc.

CV, or Curriculum Vitae, is Latin for “course of life”, and science is the pursuit of truth of the matter. CV Sciences: our identify is our mission — strengthening top quality of everyday living as a result of nature and science.

CV Sciences, Inc. (OTCQB:CVSI) operates two unique small business segments: a purchaser solution division concentrated on producing, advertising and offering plant-dependent dietary nutritional supplements and CBD products and solutions to a array of current market sectors and a drug development division concentrated on creating and commercializing CBD-based mostly novel therapeutics. The Company’s PlusCBD™ merchandise are marketed at extra than 6,200 retail spots in the course of the U.S. and it is the top-offering model of hemp-derived CBD on the market, according to SPINS, the primary service provider of syndicated data and insights for the pure, organic and specialty products marketplace. CV Sciences follows all rules for Fantastic Manufacturing Procedures (GMP) and the Company’s products and solutions are processed, created, and tested during the manufacturing approach to verify rigorous compliance with firm specifications and technical specs. With a dedication to science, PlusCBD™ products positive aspects in nutritious folks are supported by human clinical study details, in addition to three revealed clinical scenario research accessible on PubMed.gov. PlusCBD™ was the initially hemp CBD supplement model to invest in the scientific proof important to obtain self-affirmed Usually Identified as Risk-free (GRAS) position. CV Sciences, Inc. has primary places of work and services in San Diego, California. Extra data is offered from OTCMarkets.com or by traveling to www.cvsciences.com.

Forward-On the lookout DISCLAIMER

This press launch could contain certain ahead-hunting statements and info, as defined inside of the this means of Area 27A of the Securities Act of 1933 and Part 21E of the Securities Trade Act of 1934, and is topic to the Safe and sound Harbor established by these sections. This materials consists of statements about anticipated long run functions and/or financial success that are forward-seeking in nature and subject matter to pitfalls and uncertainties. This kind of forward-hunting statements by definition entail challenges, uncertainties.

Get hold of Details:
Trader Make contact with:
ICR
Scott Van Winkle
617-956-6736
scott.vanwinkle@icrinc.com

Media Get in touch with:
ICR
Cory Ziskind
646-277-1232
cory.ziskind@icrinc.com

A photograph accompanying this announcement is out there at https://www.globenewswire.com/NewsRoom/AttachmentNg/e127ef93-5838-4e15-be0f-a3ef058ea06e